No Increased Risk of Thrombosis in Heterozygous Congenital Dysplasminogenemia

スポンサーリンク

概要

• 論文の詳細を見る

著者

• Azuma Hiroyuki

  First Department of Internal Medicine, University of Tokushima, School of Medicine

• Matsumoto Toshio

  First Department of Internal Medicine, University of Tokushima, School of Medicine

• Tamaki T

  Department Of Pharmacology The Institute Of Health Bioscience The University Of Tokushima Graduate S

• Azuma Hiroyuki

  First Department Of Internal Medicine School Of Medicine The University Of Tokushima

• AZUMA Hiroyuki

  the First Department of Internal Medicine

• SHIGEKIYO Toshio

  the First Department of Internal Medicine

• SHIGEKIYO Toshio

  First Department of Internal Medicine, School of Medicine, The University of Tokushima

• KANAZUKA Masaru

  First Department of Internal Medicine, School of Medicine, The University of Tokushima

• AIHARA Kenichi

  First Department of Internal Medicine, School of Medicine, The University of Tokushima

• OHSHIMA Yasushi

  Department of Internal Medicine, Anan Kyoei Hospital

• HORIE Hidetaka

  Department of Internal Medicine, Anan Kyoei Hospital

• NAKAHIRA Haruhito

  Department of Internal Medicine, Anan Kyoei Hospital

• TAKEICHI Toshiaki

  Department of Internal Medicine, Health Insurance Naruto Hospital

• Kojima Akihiro

  Department Of Medicine And Bioregulatory Sciences The University Of Tokushima Graduate School Of Hea

• Nakahira Haruhito

  Department Of Internal Medicine Anan Kyoei Hospital

• Aihara Kenichi

  First Department Of Internal Medicine School Of Medicine The University Of Tokushima

• Kanazuka Masaru

  First Department Of Internal Medicine School Of Medicine The University Of Tokushima

• Shigekiyo Toshio

  First Department Of Internal Medicine School Of Medicine The University Of Tokushima

• Matsumoto Toshio

  First Department Of Internal Medicine Tokushima University

• Takeichi Toshiaki

  Department Of Internal Medicine Health Insurance Naruto Hospital

• Matsumoto Toshio

  First Department Of Internal Medicine And The First Department Of Pathology School Of Medicine Unive

関連論文

• Anti-neuronal Antibodies in Acute Pandysautonomia
• FRS-026 HIF-1α in T cells pathway plays a crucial role in the progression of arteriosclerosis(Novel Mechanisms in Atherosclerosis (IHD),Featured Research Session,The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
• Big Mitogen-Activated Protein Kinase 1 (BMK1)/Extracellular Signal Regulated Kinase 5 (ERK5) Is Involved in Platelet-Derived Growth Factor (PDGF)-Induced Vascular Smooth Muscle Cell Migration
• The Novel Src Kinase Inhibitor M475271 Inhibits VEGF-Induced Vascular Endothelial-Cadherin and β-Catenin Phosphorylation but Increases Their Association
• Calcium and Reactive Oxygen Species Mediated Zn^-Induced Apoptosis in PC12 Cells
• OJ-211 HIF-ARNT Transcriptional System in T Cells Has a Pivotal Role in Vascular Inflammation and Remodeling(Atherosclerosis, basic-2 (H) OJ36,Oral Presentation (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society)
• A Novel Src Kinase Inhibitor, M475271, Inhibits VEGF-Induced Human Umbilical Vein Endothelial Cell Proliferation and Migration
• Malfunction of Vascular Control in Lifestyle-Related Diseases : Formation of Systemic Hemoglobin-Nitric Oxide Complex (HbNO) From Dietary Nitrite
• S12-4 Zinc-induced cytotoxicity in PC12 cells(SYMPOSIUM 12: OXIDATIVE STRESS AND ORGAN DAMAGE)(Proceedings of the 31st Annual Meeting)
• Antioxidant Effects of Stereoisomers of N-Acetylcysteine (NAC), L-NAC and D-NAC, on Angiotensin II-Stimulated MAP Kinase Activation and Vascular Smooth Muscle Cell Proliferation
• Dual Effects of Endothelin-1 (1-31) : Induction of Mesangial Cell Migration and Facilitation of Monocyte Recruitment through Monocyte Chemoattractant Protein-1 Production by Mesangial Cells
• The Reaction Rate of Edaravone (3-Methyl-1-phenyl-2-pyrazolin-5-one (MCI-186)) with Hydroxyl Radical
• New Methods to Evaluate Endothelial Function : Evaluation of Endothelial Function by Hemoglobin-Nitric Oxide Complex Using Electron Paramagnetic Resonance Spectroscopy
• Stress and Vascular Responses: Atheroprotective Effect of Laminar Fluid Shear Stress in Endothelial Cells: Possible Role of Mitogen-Activated Protein Kinases
• PJ-070 Exaggerated Atherosclerosis in Heparin Cofactor II-Deficient ApoE Knockout Mice(Atherosclerosis, basic-8, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
• OJ-216 Acceleration of Angiotensin II-Induced Coronary Artery Remodeling in Androgen Receptor Knockout Male Mice(Atherosclerosis, basic-2 (H) OJ36,Oral Presentation (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Soci
• OE-127 Androgen-Androgen Receptor System Counteracts Doxorubicin-Induced Cardiotoxicity through Attenuating Oxidative Stress-Induced Mitochondrial Damage in Murine Male Heart(Heart failure, basic-1 (M) OE22,Oral Presentation (English),The 70th Anniversary
• Androgen Receptor Gene Knockout Male Mice Exhibit Exacerbated Cardiotoxicity and Increased Mortality by Doxorubicin Administration(Cardiac Function, Basic/Clinical 1 (M), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
• Arterial Cuff Injury Causes Enhanced Neointimal Formation and Increased Adventitial Area in Heterozygous Heparin Cofactor II Deficient Mice(Atherosclerosis, Basic 1 (IHD), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
• PJ-359 Impaired Cardiac Hypertrophic Response and Exacerbated Cardiac Fibrosis in Angiotensin Il-Loaded Male Mice Lacking Androgen Receptor(Molecular Biology, Myocardium 1 (M) : PJ60)(Poster Session (Japanese))
• OJ-373 Vitamin D/Vitamin D Receptor System Regulates Antithrombogenicity in vivo(Thromboembolism/Thrombolysis 3 (IHD) : OJ45)(Oral Presentation (Japanese))
• Heparin Cofactor II Is Inversely Related to the Severity of Carotid Atherosclerosis
• Elevated blood pressure with a cardiovascular remodeling in mice lacking vitamin D receptor
• Effect of Endothelin-1 (1-31) on Human Mesangial Cell Proliferation
• Comparison of the Effects of Endothelin-1, -2 and -3 (1-31) on Changes in [Ca^]_i in Human Coronary Artery Smooth Muscle Cells
• Plasma Levels of Free and Sulfoconjugated Catecholamines in Patients with Atherosclerosis
• Changes in Plasma Free and Sulfoconjugated Catecholamines during the Perioperative Period of Cardiac Surgery : Effect of Continuous Infusion of Dopamine
• PE-347 Early Detection of Myocardial Damage in Female Carriers of Duchenne Muscular Dystrophy : the Utility of Cardiac Magnetic Resonance(PE058,Cardiomyopathy/Hypertrophy (Clinical) 1 (M),Poster Session (English),The 73rd Annual Scientific Meeting of The
• DPE-042 Plasma Aldosterone Concentration is Associated with Cognitive Impairement in Patients with Hypertension(DPE07,Hypertension, Clinical (H),Digital Poster Session (English),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
• OE-366 Bosentan, an Endothelin Receptor Antagonist, Exerts Protective Actions against Systemic Sclerosis-related Peripheral Circulation Insufficiency(OE62,Peripheral Circulation/Vascular Disease (Therapy) (H),Oral Presentation (English),The 73rd Annual Sc
• OE-213 Pitavastatin Exerts LDL Cholesterol Reduction-independent Protective Action for Cardiac and Renal Function in Patients with Dyslipidemia(OE36,Atherosclerosis (Clinical/Treatment) (IHD),Oral Presentation (English),The 73rd Annual Scientific Meeting
• Heparin Cofactor II is an Independent Protective Factor against Peripheral Arterial Disease in Elderly Subjects with Cardiovascular Risk Factors
• PE-209 Pitavastatin Excretes eNOS-independent Protective Action against Angiotensin II-induced Atrial Remodeling through Attenuating Rac1-madiated Oxidative Stress(PE035,Cardiovascular Pharmacology (Basic) (H),Poster Session (English),The 73rd Annual Scie
• PE-163 HMG-CoA Reductase Inhibitor Pitavastatin Increases the Expression of Endothelial NOS through Activation of ERK5-KLF2 Pathway in Vascular Endothelial Cells(Cardiovascular pharmacology, basic/clinical(03)(H),Poster Session(English),The 72nd Annual Sc
• OE-024 An eNOS-independent Protective Action of Pitavastatin against Angiotensin II-induced Cardiorenal Damage through Attenuating Rac-1-mediated Oxidative Stress(Cardiovascular pharmacology, basic/clinical(01)(H),Oral Presentation(English),The 72nd Annua
• PE-570 Therapeutic Angiogenesis by Transplantation of Atologous Peripheral-blood Mononuclear Cells Mobilized by Human Recombinant Erythropoietin in Patients with Severe Limb Ischemia(Regeneration (angiogenesis/myocardial regeneration)-4, The 71st Annual S
• PE-390 Glucocorticoid-induced Vascular Endothelial Dysfunction and Hypertension are Ameliorated by Pitavastatin, an HMG-CoA Reductase Inhibitor, through Increased Nitric Oxide Production(Cardiovascular pharmacology, basic/clinical-4, The 71st Annual Scien
• OE-211 A Novel eNOS-independent Action of an HMG-CoA Reductase Inhibitor against Angiotensin II-induced Cardiovascular Remodeling(Cardiovascular pharmacology, basic/clinical-1, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
• Intra-Vascular Ultrasound Findings of Diffuse Coronary Atherosclerotic Change in Systemic Lupus Erythematosus With Secondary Antiphospholipid Syndrome
• PE-434 Thrombin Inactivation by Synthetic Thrombin Antagonist Argatroban Ameliorates Insulin Resistance in Type 2 Diabetic db/db Mice(Diabetes/Obesity/Metabolic syndrome-4 (H) PE73,Poster Session (English),The 70th Anniversary Annual Scientific Meeting of
• OJ-077 Improvement of Cardiac Function in Response to Carvedilol is Accompanied by Increased Adiponectin Levels in Patients with Chronic Heart Failure(Heart failure, clinical-3 (M) OJ13,Oral Presentation (Japanese),The 70th Anniversary Annual Scientific M
• OE-138 Plasma Heparin Cofactor II Activity is Inversely Associated with Prevalence of Peripheral Arterial Disease in Elderly individuals(Peripheral circulation-1 (H) OE23,Oral Presentation (English),The 70th Anniversary Annual Scientific Meeting of the Ja
• Prompt Decrease of BNP in Early Phase can be a Novel Predictor for Future Effectiveness of Carvedilol in CHF Patients(Heart Failure, Clinical 6 (M), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
• Pitavastatin Inhibits TNF-α-induced NF-κB Transcriptional Activation through BMK1/ERK5 Activation in Vascular Endothelial Cells(Endothelium/NO 1 (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
• Angiotensin II Antagonist Valsartan Ameliorates Nitric Oxide Bioavailability Accompanied with the Reduction of Blood Pressure and Pulse Pressure in Hypertensives(Hypertension, Clinical 5 (H), The 69th Annual Scientific Meeting of the Japanese Circulation
• Downregulation of Mitochondrial Transcription Factors Play an Important Role in Cardiac Transition From Hypertensive Left Ventricular Hypertrophy to Heart Failure(Heart Failure, Basic 2 (M), The 69th Annual Scientific Meeting of the Japanese Circulation S
• Effect of angiotensin II on iron-transporting protein expression and subsequent intracellular labile iron concentration in human glomerular endothelial cells
• Adiponectin inhibits insulin-like growth factor-1-induced cell migration by the suppression of extracellular signal-regulated kinase 1/2 activation, but not Akt in vascular smooth muscle cells
• Quercetin Glucuronide Inhibits Cell Migration and Proliferation by Platelet-Derived Growth Factor in Vascular Smooth Muscle Cells
• Drug Discovery for Overcoming Chronic Kidney Disease (CKD) : Development of Drugs on Endothelial Cell Protection for Overcoming CKD
• PE-564 Dehydroepiandrosterone Sulfate is an Antivascular Remodeling Factor(PE095,Atherosclerosis (Clinical/Pathophysiology) (IHD),Poster Session (English),The 73rd Annual Scientific Meeting of the Japanese Circulation Society)
• DPE-065 A Combination of Erythropoietin Administration with Autologous Blood Donation for Therapeutic Angiogenesis(DPE11,Kidney/Renal Circulation/CKD (H),Digital Poster Session (English),The 73rd Annual Scientific Meeting of The Japanese Circulation Socie
• FRS-005 Heparin Cofactor II-deficient Mice Exert Exacerbation of Angiotensin II-induced Cardiac Remodeling through Enhancement of NADPH oxidase-TGF-β1 Pathway(FRS1,New Molecules for Cardiovascular Regulation (M),Featured Research Session (English),The 73r
• OE-322 Impact of Acute Changes in Serum Insulin-like Growth Factor-1 on Prognosis of Acute Myocardial Infarction(Acute myocardial infarction, clinical(pathophysiology)(01)(IHD),Oral Presentation(English),The 72nd Annual Scientific Meeting of the Japanese
• PJ-308 Plasma Heparin Cofactor II Activity is Associated with Plaque Vulnerability in Patients with Stable Angina Pectoris(Atherosclerosis, clinical-10, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
• PJ-295 PPARα activators suppress PDGF-BB in human megakaryotic tumor cell lines(Atherosclerosis, Basic 3 (IHD) : PJ50)(Poster Session (Japanese))
• PE-047 Aspirin Ameliorates Impaired Production of Endothelial Nitric Oxide in Glucocorticoid Excess(Endothelium/NO 1 (H) : PE8)(Poster Session (English))
• OJ-416 Aspirin and Pitavastatin Increase Expression of Aminopeptidase N/CD13 through the Activation of Akt(Endothelium/NO 5 (H) : OJ51)(Oral Presentation (Japanese))
• Antisense Oligonucleotide against Mitochondrial Transcription Factor a (mtTFA) Can Attenuate the Neointimal Formation in a Rat Balloon Injury Model
• Pitavastatin (NK-104) Exerts Vasculo-Protective Action by Upregulation of Endothelial Aminopeptidase N (APN/CD13) Expression
• Apo(a) stimulates the dedifferentiation of vascular smooth muscle cells though the impaired activation of TGF-β in human early atherosclerotic lesions
• Elevated Heparin Cofactor II can Reduce In-stent Restenosis After Percutaneous Coronary Intervention
• Heparin Cofactor II as a Novel Vascular Protective Factor Against Atherosclerosis
• Effects of Angiotensin II Type 1 Receptor Blockade on the Systemic Blood Nitric Oxide Dynamics in N^ω-Nitro-L-Arginine Methyl Ester-Treated Rats
• Prevalence of Idiopathic Hypoparathyroidism and Pseudohypoparathyroidism in Japan
• Successful Combination Therapy - Flunarizine, Pentoxifylline, and Cholestyramine - for Spur Cell Anemia
• Dermatomyositis with Peripheral Nervous System Involvement : Activation of Vascular Endothelial Growth Factor (VEGF) and VEGF Receptor (VEGFR) in Vasculitic Lesions
• A Patient with Cyclic Neutropenia Complicated by Severe Persistent Neutropenia Successfully Delivered a Healthy Baby
• A Case Report of an Elderly Patient with Acromegaly
• No Increased Risk of Thrombosis in Heterozygous Congenital Dysplasminogenemia
• PE-011 Plasma Heparin Cofactor II Activity is a Predictor of Morphological Characteristics of Coronary Arteries Diffuse-Narrowing in Patients with Diabetes Mellitus(Angina pectoris, basic/clinical-2, The 71st Annual Scientific Meeting of the Japanese Circ
• OJ-059 Plasma Heparin Cofactor II Activity Predicts Cardio-and Cerebrovascular Events in Patients with Coronary Heart Disease(Preventive medicine/Epidemiology/Education-2 (H) OJ10,Oral Presentation (Japanese),The 70th Anniversary Annual Scientific Meeting
• Successful Treatment with Tacrolimus in a Case of Refractory Dermatomyositis
• Electron Paramagnetic Resonance Study on Free Radical Scavenging and/or Generating Activity of Dopamine-4-O-sulfate
• Antioxidants Inhibit JNK and p38 MAPK Activation but not ERK 1/2 Activation by Angiotensin II in Rat Aortic Smooth Muscle Cells
• Diurnal Fluctuation of Edema Synchronized with Plasma VEGF Concentration in a Patient with POEMS Syndrome
• Detection of diatom in formalin-fixed organs by enzymatic digestion
• Intracellular Degradation of Histidine-Rich Glycoprotein Mutants: Tokushima-1 and 2 Mutants Are Degraded by Different Proteolytic Systems
• High plasma aldosterone concentration is a novel risk factor of cognitive impairment in patients with hypertension
• Dermatomyositis with Peripheral Nervous System Involvement : Activation of Vascular Endothelial Growth Factor (VEGF) and VEGF Receptor (VEGFR) in Vasculitic Lesions
• Heparin Cofactor 2 Is a Novel Protective Factor Against Carotid Atherosclerosis in Elderly Individuals
• Superantigens and Autoantigens May Be Involved in the Pathogenesis of Gastric Mucosa-Associated Lymphoid Tissue Lymphoma
• PJ-812 Angiotensin II-induced Cardiac Remodeling is Exacerbated with Increased Oxidative Stress in Heparin Cofactor II-deficient Mice(Cardiovascular pharmacology, basic / clinical(06)(H),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the J
• PE-498 1 α 25 dihydroxyvitamin D_3 is a protective factor against vascular remodeling and glucose tolerance in elderly individuals(Atherosclerosis, clinical(08)(IHD),Poster Session(English),The 72nd Annual Scientific Meeting of the Japanese Circulation So
• OJ-074 Plasma Heparin Cofactor II Activity is Inversely Associated with Left Atrial Size in Elderly Individuals(Cardiac function, basic/clinical(02)(M),Oral Presentation(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
• Pharmacology in Health Food : Metabolism of Quercetin In Vivo and Its Protective Effect Against Arteriosclerosis
• Pathophysiological Response to Hypoxia-From the Molecular Mechanisms of Malady to Drug Discovery : Inflammatory Responses of Hypoxia-Inducible Factor 1α (HIF-1α) in T Cells Observed in Development of Vascular Remodeling
• Microglial and astrocytic changes in the striatum of methamphetamine abusers
• Signal transduction of reactive oxygen species and mitogen-activated protein kinases in cardiovascular disease
• Current understanding of bone cell differentiation: An Evening Seminar of the 18th Annual Meeting of the Japanese Society for Bone and Mineral Research, July 20,2000

もっと見る 閉じる

スポンサーリンク